US Sinus Surgery Market Trends & Forecasts 2021

MarketReportsOnline.com adds “US Drug Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts (2016-2021)” research report of 76 pages on the drug eluting sinus stent industry to the medical devices intelligence collection of its research store.

The report entitled “US Drug Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts (2016-2021)”, provides analysis of the US DESS market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The analysis includes the market by value (TAM), by volume and by utilization. The report also provides the analysis of the US sinus surgery market, including analysis of FESS market and BSD market.

Complete report available at http://www.marketreportsonline.com/500312.html.

Furthermore, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall US DESS market has also been forecasted for the years 2016-2021, taking into consideration the growth pattern of sinus surgery market, the growth drivers and the current and future trends.

Intersect is the only company manufacturing drug eluting sinus stents, but the competitive landscape of the market includes other indirect competitors, such as Medtronic, Entellus Medical and Acclarent (J&J), whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.

Company Coverage

• Intersect ENT
• Medtronic (Xomed)
• Entellus Medical
• Acclarent (J&J)

Sinuses are the hollow cavities located in the bones of the face and around the nose. There are four sinus cavities: frontal, maxillary, ethmoid, and sphenoid, each with different features. Under normal conditions, the secretion (mucous) flow through the nasal passages, but with the onset of sinusitis, the secretion gets blocked in the sinuses due to inflammation. Sinusitis disturbs the normal lifestyle of a person and sometimes become frustrating, as it affects the person’s breathing, sleeping and eating.

Purchase a copy of this “US Drug Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts (2016-2021)” research report at USD 900 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=500312.

Sinusitis can be divided into Acute Sinusitis, Recurrent Acute Rhinosinusitis (RARS) and chronic Rhinosinusitis (CRS), on the basis of the duration of the episode of sinusitis and its severity. The treatment options for the sinusitis can be over-the-counter treatment, medical management and surgery. The OTC treatment includes decongestants, antihistamines, pain relievers and nasal irrigation. Medical management includes antibiotics and oral and nasal steroids. The sinus surgeries are mainly of two types: Functional Endoscopic Sinus Surgery (FESS) and Balloon Sinus Dilation (BSD).

Intersect, is the only company that has developed drug releasing bio-absorbable implants (drug eluting sinus stents- DESS) that enable targeted and sustained release of therapeutic agents, increasing the effectiveness of the sinus surgery.

The US DESS market is expected to increase at a significant growth rate during the forecasted period (2016-2021). The US DESS market is supported by various growth drivers, such as limitations of FESS treatment, benefits of DESS, increasing per capita healthcare expenditure, cost effectiveness of DESS, etc. Yet, the market faces certain challenges, such as, reimbursement issues, dependability on individual physician’s experience, limited trials after BSD, etc.

Browse Other Latest Reports on Medical Devices Market:

Europe – Self Monitoring of Blood Glucose (SMBG) (Test Strips, Lancet, Meter) Market and Forecast: Self-monitoring of blood glucose is a very lucrative business with enormous market opportunity. Self-monitoring of blood glucose (SMBG) is an important component of modern therapy for diabetes mellitus. SMBG has been recommended for people with diabetes and their health care professionals in order to achieve a specific level of glycemic control and to prevent hypoglycemia.

High Intensity Focused Ultrasound (HIFU) – Company Profile, Recent Development and Product Analysis: High-intensity focused ultrasound (HIFU) is a promising non-invasive thermal ablation technique. HIFU treatment is a highly precise and non-invasive treatment procedure using high intensity, focused ultrasound to heat and destroy diseased tissue. The history of using therapeutic ultrasound dates back to early in the 20th century. Technology has continually improved and additional clinical applications, both diagnostic and therapeutic, have become an integral part of medicine today. In HIFU treatment, Ultrasound beams are focused on diseased tissue, and due to the significant energy deposition at the focus, temperature within the tissue rises to more than 65°C, destroying the diseased tissue.

Global Spinal Cord Stimulation Market DataPack (2016-2018)

Global Robotic Surgery Market DataPack – 2016 Edition

Global Glucose Monitoring Market DataPack – Focus on CGM (2016-2020)

About Us:
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Contact Us:
Ritesh Tiwari
2nd Floor, Metropole,
Next to Inox Theatre,
Bund Garden Road,
Pune – 411001.
Maharashtra, India.
Tel: + 1 888 391 5441
E-mail: [email protected]